Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Preferred Shares (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Preferred Shares for 9 consecutive years, with $4.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Preferred Shares changed 0.0% year-over-year to $4.0, compared with a TTM value of $4.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $4.0, changed 0.0% over the prior year.
  • Preferred Shares was $4.0 for Q3 2025 at Kiora Pharmaceuticals, roughly flat from $4.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $41.0 in Q1 2021 and bottomed at $4.0 in Q4 2023.
  • Average Preferred Shares over 4 years is $10.75, with a median of $4.0 recorded in 2023.
  • The sharpest move saw Preferred Shares changed 0.0% in 2021, then crashed 60.0% in 2024.
  • Year by year, Preferred Shares stood at $41.0 in 2021, then crashed by 90.24% to $4.0 in 2023, then changed by 0.0% to $4.0 in 2024, then changed by 0.0% to $4.0 in 2025.
  • Business Quant data shows Preferred Shares for KPRX at $4.0 in Q3 2025, $4.0 in Q2 2025, and $4.0 in Q1 2025.